首页> 外文OA文献 >Cyclophosphamide (NSC 26271) versus the combination of adriamycin (NSC 123127), 5-fluorouracil (NSC 19893), and cyclophosphamide in the treatment of metastatic prostatic cancer. A randomized trial

【2h】

Cyclophosphamide (NSC 26271) versus the combination of adriamycin (NSC 123127), 5-fluorouracil (NSC 19893), and cyclophosphamide in the treatment of metastatic prostatic cancer. A randomized trial

机译：环磷酰胺（NSC 26271）与Adriamycin（NSC 123127），5-氟尿嘧啶（NSC 19893）的组合，以及环磷酰胺治疗转移前列腺癌。随机试验

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Rowan T. Chlebowski; Robert Hestorff; Leonard Sardoff; John Weiner; Joseph R. Bateman;
展开▼
作者单位

展开▼
年度 1978
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Accelerated versus standard cyclophosphamide, epirubicin and 5-fluorouracil or cyclophosphamide, methotrexate and 5-fluorouracil: a randomized phase III trial in locally advanced breast cancer. [J] . Baldini E, Gardin G, Giannessi PG, Annals of oncology: official journal of the European Society for Medical Oncology . 2003,第2期

机译：与标准环磷酰胺，表柔比星和5-氟尿嘧啶或环磷酰胺，甲氨蝶呤和5-氟尿嘧啶相比，加速治疗：在局部晚期乳腺癌中进行的一项随机III期试验。
2. Randomized phase III trial of adjuvant epirubicin followed by cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) versus CMF followed by epirubicin in patients with node-negative or 1-3 node-positive rapidly proliferating breast cancer. [J] . Amadori D, Silvestrini R, De Lena M, Breast cancer research and treatment. . 2011,第3期

机译：在淋巴结阴性或1-3淋巴结阳性的快速增生乳腺癌患者中，进行佐剂表柔比星，环磷酰胺，甲氨蝶呤和5-氟尿嘧啶（CMF）与CMF联合表柔比星的III期随机试验。
3. Bendamustine prolongs progression-free survival in metastatic breast cancer (MBC): a phase III prospective, randomized, multicenter trial of bendamustine hydrochloride, methotrexate and 5-fluorouracil (BMF) versus cyclophosphamide, methotrexate and 5 [J] . von Minckwitz G, Sirakova L, Souchon R, Anti-cancer drugs . 2005,第8期

机译：苯达莫司汀延长转移性乳腺癌（MBC）的无进展生存期：盐酸苯达莫司汀，甲氨蝶呤和5-氟尿嘧啶（BMF）与环磷酰胺，甲氨蝶呤和5的III期前瞻性，随机，多中心试验
4. Randomized, sham-controlled trial based on transcranial direct current stimulation and wrist robot-assisted integrated treatment on subacute stroke patients: Intermediate results [C] . Stefano Mazzoleni, Vi Do Tran, Laura Iardella, 2017 International Conference on Rehabilitation Robotics . 2017

机译：基于经颅直流电刺激和腕机器人辅助综合治疗的亚急性中风患者的随机，假对照试验：中间结果
5. Transcription-Based Molecular Imaging and Gene Therapy for Castration-resistant and Metastatic Prostate Cancer in Translational Models [D] . Jiang, Ziyue 2013

机译：基于转录的分子模型和基因治疗转化模型中去势抵抗和转移性前列腺癌的研究
6. A multicenter phase III prospective randomized trial of high-dose epirubicin in combination with cyclophosphamide (EC) versus docetaxel followed by EC in node-positive breast cancer. GOIM (Gruppo Oncologico Italia Meridionale) 9902 study [O] . P. Vici, M. Brandi, F. Giotta, -1

机译：高剂量表柔比星联合环磷酰胺（EC）与多西他赛联合EC联合治疗淋巴结阳性乳腺癌的多中心III期前瞻性随机试验。 GOIM（Gruppo Oncologico Italia Meridionale）9902研究
7. Cyclophosphamide versus cyclophosphamide, methotrexate, and 5-fluorouracil in advanced prostatic cancer: A randomized trial [O] . Hyman B. Muss, Virginia Howard, Frederick Richards Ii, 1981

机译：环磷酰胺与环磷酰胺，甲氨蝶呤和晚期前列腺癌中的5-氟尿嘧啶：随机试验
8. Comparative Toxicity of 5-Fluorouracil (NSC-19893), Ftorafur (NSC-148958),and Fluorodopan (NSC-73754) in Dogs and Monkeys. [R] . thake, daryl c. denlinger, r. h. 1977

机译：5-氟尿嘧啶（NsC-19893），Ftorafur（NsC-148958）和Fluorodopan（NsC-73754）在狗和猴中的比较毒性。

Cyclophosphamide (NSC 26271) versus the combination of adriamycin (NSC 123127), 5-fluorouracil (NSC 19893), and cyclophosphamide in the treatment of metastatic prostatic cancer. A randomized trial

著录项

引文网络

相似文献

相关主题

期刊订阅